US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist
  • 7.840
  • +0.210+2.75%
Trading Sep 13 11:18 ET
414.79MMarket Cap-698P/E (TTM)

Emergent BioSolutions Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Emergent BioSolutions Q2 2024 Earnings Date

Currency：USDAug 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
190.00M
254.70M
+64.70M
Beat Est.
-43.77%
-24.62%
+34.05%
EPS
-1.30
-5.38
-4.08
Miss Est.
+74.76%
-4.26%
-313.88%
Analyst Rating
Buy

Aug 31, 2024

Emergent BioSolutions Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 267.000M--
--2024/Q3-- / 305.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--
May 1, 20242024/Q1300.400M / 220.250M--
Mar 6, 20242023/Q4276.600M / 274.000M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 267.000M--
--2024/Q3-- / 305.500M--
Aug 6, 20242024/Q2254.700M / 190.000M--
May 1, 20242024/Q1300.400M / 220.250M--
Mar 6, 20242023/Q4276.600M / 274.000M--

Unlock Free Earnings Estimates

Emergent BioSolutions Earnings Reports

  • Emergent BioSolutions | 10-Q: Q2 2024 Earnings Report

    Aug 7 14:33 ET

  • Emergent BioSolutions | 10-Q: Q1 2024 Earnings Report

    May 2 13:50 ET

  • Emergent BioSolutions | 10-K: FY2023 Annual Report

    Mar 8 16:28 ET

  • Emergent BioSolutions | 10-Q: Q3 2023 Earnings Report

    Dec 11, 2023 07:24 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Mpox (monkeypox)
    Mpox (monkeypox)
    Intraday+0.33%